Stock Events

SOPHiA Genetics SA 

€2.9
10
-€0.3-9.38% Friday 06:02

Statistics

Day High
2.9
Day Low
2.9
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

5
NOV
Earnings
 

Earnings

5NovExpected
Q4 2023
Q1 2024
Q2 2024
Next
-0.34
-0.29
-0.24
-0.2
Expected EPS
-0.19729217999999998
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 90B.F. It's not an investment recommendation.
Alphabet
75333
GOOGL
Apple
65621
AAPL
Microsoft
61102
MSFT
Amazon
56572
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.93B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with SOPHiA Genetics' data-driven analysis.
Pacific Biosciences of California
PACB
Mkt Cap373.36M
Pacific Biosciences offers long-read sequencing technologies that compete with SOPHiA Genetics in the genomic analysis and clinical diagnostics market.
Guardant Health
GH
Mkt Cap3.15B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with SOPHiA Genetics in the oncology diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap683.49M
Fulgent Genetics offers comprehensive genetic testing and competes with SOPHiA Genetics in the genetic analysis and diagnostics market.
Qiagen NV
QGEN
Mkt Cap10.16B
Bionano Genomics
BNGO
Mkt Cap42.14M
Bionano Genomics focuses on genomic analysis with its Saphyr system, competing in the structural variation analysis market alongside SOPHiA Genetics.
Exact Sciences
EXAS
Mkt Cap11.4B
Exact Sciences specializes in cancer diagnostics, including molecular screening tests, competing with SOPHiA Genetics in the molecular diagnostics market.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific offers a wide range of solutions for genetic analysis and diagnostics, making it a broad competitor to SOPHiA Genetics in the life sciences sector.
Intellia Therapeutics
NTLA
Mkt Cap2.28B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that could compete with SOPHiA Genetics in the future of genetic diagnostics and therapeutics.

About

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Show more...
CEO
Employees
430
Country
CH
ISIN
CH1125843347
WKN
000A3CVT8

Listings

F
DE
90B.F
XNAS
US
SOPH